• Skip to Main Content
  • Screen Reader Access
  • A+ A A -
  • A A

Technology Development Board enters into an agreement with Panacea Biotech

Details

To provide financial assistance of Rs 28.99 crores for the development and commercialisation of dengue tetravalent vaccine.

Panacea Biotec has signed an agreement with Technology Development Board (TDB), Govt of India for providing the financial assistance of Rs 28.99 crores for the development and commercialisation of dengue tetravalent vaccine (Live Attenuated, Recombinant, Lyophilized).”